Literature DB >> 10329737

Activation of an MDM2-specific caspase by p53 in the absence of apoptosis.

R Pochampally1, B Fodera, L Chen, W Lu, J Chen.   

Abstract

Cells undergoing p53-mediated apoptosis activate caspase 3-like activities, resulting in the cleavage of the MDM2 oncoprotein and other apoptotic substrates such as poly(ADP-ribose) polymerase. To investigate the mechanism of p53-mediated apoptosis and to determine whether cleavage of MDM2 has a potential role in regulating p53, we examined caspase activation and cleavage of MDM2 in a cell line undergoing p53-mediated growth arrest and delayed apoptosis. We found that in H1299 cells expressing a temperature-sensitive human p53, a distinct caspase activity specific for the MDM2 cleavage site DVPD is induced by p53 prior to the onset of apoptosis and loss of viability. This is accompanied by the cleavage of MDM2 but not the apoptotic substrate poly(ADP-ribose) polymerase. The cleaved MDM2 loses the ability to promote p53 degradation and may potentially function in a dominant-negative fashion to stabilize p53. These results suggest that p53 activation may induce a positive feedback effect by cleavage of MDM2 through a unique caspase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329737     DOI: 10.1074/jbc.274.21.15271

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

Authors:  Jun Li; Mingjia Tan; Ling Li; Deepika Pamarthy; Theodore S Lawrence; Yi Sun
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  The coordinate regulation of the p53 and mTOR pathways in cells.

Authors:  Zhaohui Feng; Haiyan Zhang; Arnold J Levine; Shengkan Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

3.  Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications.

Authors:  Li-Ju Chang; Alan Eastman
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

4.  Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes.

Authors:  C Kositprapa; B Zhang; S Berger; J M Canty; T C Lee
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 5.  Mdm2 links genotoxic stress and metabolism to p53.

Authors:  Zhongfeng Wang; Baojie Li
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

6.  DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.

Authors:  Koji Okamoto; Kenji Kashima; Yaron Pereg; Michiko Ishida; Satomi Yamazaki; Ayumi Nota; Amina Teunisse; Domenico Migliorini; Issay Kitabayashi; Jean-Christophe Marine; Carol Prives; Yosef Shiloh; Aart G Jochemsen; Yoichi Taya
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Progesterone inhibition of MDM2 p90 protein in MCF-7 human breast cancer cell line is dependent on p53 levels.

Authors:  Moussa Alkhalaf; Abdalla M El-Mowafy; Laila A Abou-Zeid
Journal:  J Mol Genet Med       Date:  2005-08-19

8.  p53 responsive elements in human retrotransposons.

Authors:  C R Harris; A Dewan; A Zupnick; R Normart; A Gabriel; C Prives; A J Levine; J Hoh
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

9.  MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.

Authors:  Wei Fu; Qiuping Ma; Lei Chen; Pengfei Li; Mu Zhang; Sivapriya Ramamoorthy; Zafar Nawaz; Tsukasa Shimojima; Hengbin Wang; Yonghua Yang; Zheng Shen; Yingtao Zhang; Xiaohong Zhang; Santo V Nicosia; Yanping Zhang; Jack W Pledger; Jiandong Chen; Wenlong Bai
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

10.  ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence.

Authors:  Lijun Jia; Maria S Soengas; Yi Sun
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.